Pharmaceutical Sterility Testing Market Research Report Information By Sample (Sterile Drugs, Medical Devices, Biologics), By Product Type (Instruments, Kits & Reagents, Services), By Type (In-house, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing), By End User (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Impact on Supply Chain

5.3.3. Regional Impact

5.3.4. Opportunity and Threat Analysis

6. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE

6.1. Overview

6.2. Sterile Drugs

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3. Medical Devices

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.4. Biologics

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

7. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE

7.1. Overview

7.2. Instruments

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

7.3. Kits & Reagents

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

7.4. Services

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE

8.1. Overview

8.2. In-house

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8.3. Outsourcing

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE

9.1. Overview

9.2. Sterility Testing

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9.3. Bioburden Testing

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9.4. Bacterial Endotoxin Testing

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

10. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER

10.1. Overview

10.2. Compounding Pharmacies

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

10.3. Medical Devices Companies

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

10.4. Pharmaceutical Companies

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

10.5. Others

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

11. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY REGION

11.1. Overview

11.2. North America

11.2.1. US

11.2.2. Canada

11.3. Europe

11.3.1. Germany

11.3.2. France

11.3.3. Italy

11.3.4. Spain

11.3.5. UK

11.3.6. Rest of Europe

11.4. Asia-Pacific

11.4.1. Japan

11.4.2. China

11.4.3. India

11.4.4. Australia

11.4.5. South Korea

11.4.6. Rest of Asia-Pacific

11.5. Rest of the World

11.5.1. Middle East

11.5.2. Africa

11.5.3. Latin America

12. COMPANY LANDSCAPE

12.1. Overview

12.2. Competitive Analysis

12.3. Market Share Analysis

12.4. Major Growth Strategy in the Global Pharmaceutical Sterility Testing Market

12.5. Competitive Benchmarking

12.6. Leading Players in terms of Number of Developments in the Global Pharmaceutical Sterility Testing Market

12.7. Key developments and Growth Strategies

12.7.1. New Product Launch/Service Deployment

12.7.2. Mergers & Acquisitions

12.7.3. Joint Ventures

12.8. Major Players Financial Matrix

12.8.1. Sales & Operating Income, 2020

12.8.2. Major Players R&D Expenditure, 2020

13. COMPANY PROFILES

13.1. Merck KGaA

13.1.1. Company Overview

13.1.2. Key Financials

13.1.3. Products Offered

13.1.4. Key Developments

13.1.5. SWOT Analysis

13.1.6. Key Strategies

13.2. Rapid Micro Biosystems

13.2.1. Company Overview

13.2.2. Key Financials

13.2.3. Products Offered

13.2.4. Key Developments

13.2.5. SWOT Analysis

13.2.6. Key Strategies

13.3. Sartorius AG

13.3.1. Company Overview

13.3.2. Key Financials

13.3.3. Products Offered

13.3.4. Key Developments

13.3.5. SWOT Analysis

13.3.6. Key Strategies

13.4. Solvias AG

13.4.1. Company Overview

13.4.2. Key Financials

13.4.3. Products Offered

13.4.4. Key Developments

13.4.5. SWOT Analysis

13.4.6. Key Strategies

13.5. SGS SA

13.5.1. Company Overview

13.5.2. Key Financials

13.5.3. Products Offered

13.5.4. Key Developments

13.5.5. SWOT Analysis

13.5.6. Key Strategies

13.6. Boston Analytical

13.6.1. Company Overview

13.6.2. Key Financials

13.6.3. Products Offered

13.6.4. Key Developments

13.6.5. SWOT Analysis

13.6.6. Key Strategies

13.7. BioMérieux, Inc.

13.7.1. Company Overview

13.7.2. Key Financials

13.7.3. Products Offered

13.7.4. Key Developments

13.7.5. SWOT Analysis

13.7.6. Key Strategies

13.8. Charles River Laboratories International, Inc.

13.8.1. Company Overview

13.8.2. Key Financials

13.8.3. Products Offered

13.8.4. Key Developments

13.8.5. SWOT Analysis

13.8.6. Key Strategies

13.9. Thermo Fisher Scientific, Inc.

13.9.1. Company Overview

13.9.2. Key Financials

13.9.3. Products Offered

13.9.4. Key Developments

13.9.5. SWOT Analysis

13.9.6. Key Strategies

13.10. Pace Analytical Services, LLC

13.10.1. Company Overview

13.10.2. Key Financials

13.10.3. Products Offered

13.10.4. Key Developments

13.10.5. SWOT Analysis

13.10.6. Key Strategies

13.11. Toxikon, Inc.

13.11.1. Company Overview

13.11.2. Key Financials

13.11.3. Products Offered

13.11.4. Key Developments

13.11.5. SWOT Analysis

13.11.6. Key Strategies

13.12. Sotera Health

13.12.1. Company Overview

13.12.2. Key Financials

13.12.3. Products Offered

13.12.4. Key Developments

13.12.5. SWOT Analysis

13.12.6. Key Strategies

13.13. Pacific Biolabs Inc.

13.13.1. Company Overview

13.13.2. Key Financials

13.13.3. Products Offered

13.13.4. Key Developments

13.13.5. SWOT Analysis

13.13.6. Key Strategies

13.14. STRERIS Corporation

13.14.1. Company Overview

13.14.2. Key Financials

13.14.3. Products Offered

13.14.4. Key Developments

13.14.5. SWOT Analysis

13.14.6. Key Strategies

13.15. WuXi AppTec

13.15.1. Company Overview

13.15.2. Key Financials

13.15.3. Products Offered

13.15.4. Key Developments

13.15.5. SWOT Analysis

13.15.6. Key Strategies

14. APPENDIX

14.1. References

14.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SYNOPSIS, 2022–2030

TABLE 2 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET ESTIMATES & FORECAST, 2022– 2030 (USD MILLION)

TABLE 3 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 4 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 5 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 6 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 7 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 8 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)

TABLE 9 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 10 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 11 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 12 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 13 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 14 US: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 15 US: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 16 US: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 17 US: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 18 US: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 19 CANADA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 20 CANADA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 21 CANADA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 22 CANADA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 23 CANADA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 24 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)

TABLE 25 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 26 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 27 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 28 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 29 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 30 GERMANY: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 31 GERMANY: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 32 GERMANY: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 33 GERMANY: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 34 GERMANY: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 35 FRANCE: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 36 FRANCE: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 37 FRANCE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 38 FRANCE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 39 FRANCE: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 40 ITALY: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 41 ITALY: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 42 ITALY: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 43 ITALY: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 44 ITALY: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 45 SPAIN: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 46 SPAIN: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 47 SPAIN: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 48 SPAIN: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 49 SPAIN: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 50 UK: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 51 UK: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 52 UK: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 53 UK: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 54 UK: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 55 REST OF EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 56 REST OF EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 57 REST OF EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 58 REST OF EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 59 REST OF EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 60 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)

TABLE 61 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 62 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 63 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 64 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 65 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 66 JAPAN: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 67 JAPAN: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 68 JAPAN: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 69 JAPAN: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 70 JAPAN: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 71 CHINA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 72 CHINA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 73 CHINA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 74 CHINA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 75 CHINA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 76 INDIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 77 INDIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 78 INDIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 79 INDIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 80 INDIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 81 AUSTRALIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 82 AUSTRALIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 83 AUSTRALIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 84 AUSTRALIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 85 AUSTRALIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 86 SOUTH KOREA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 87 SOUTH KOREA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 88 SOUTH KOREA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 89 SOUTH KOREA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 90 SOUTH KOREA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 91 REST OF ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 92 REST OF ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 93 REST OF ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 94 REST OF ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 95 REST OF ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 96 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY REGION, 2022–2030 (USD MILLION)

TABLE 97 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 98 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 99 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 100 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 101 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 102 MIDDLE EAST: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 103 MIDDLE EAST: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 104 MIDDLE EAST: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 105 MIDDLE EAST: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 106 MIDDLE EAST: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 107 AFRICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 108 AFRICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 109 AFRICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 110 AFRICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 111 AFRICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 112 LATIN AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)

TABLE 113 LATIN AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)

TABLE 114 LATIN AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)

TABLE 115 LATIN AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)

TABLE 116 LATIN AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET

FIGURE 4 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY SAMPLE, 2020 (%)

FIGURE 5 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY PRODUCT TYPE, 2020 (%)

FIGURE 6 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY TYPE, 2020 (%)

FIGURE 7 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY TEST TYPE, 2020 (%)

FIGURE 8 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY END USER, 2020 (%)

FIGURE 9 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 12 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 13 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 14 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 MERCK KGAA PHARMACEUTICALS: FINANCIAL OVERVIEW

FIGURE 16 MERCK KGAA PHARMACEUTICALS: SWOT ANALYSIS

FIGURE 17 RAPID MICRO BIOSYSTEMS: FINANCIAL OVERVIEW

FIGURE 18 RAPID MICRO BIOSYSTEMS: SWOT ANALYSIS

FIGURE 19 SARTORIUS AG: FINANCIAL OVERVIEW

FIGURE 20 SARTORIUS AG: SWOT ANALYSIS

FIGURE 21 SOLVIAS AG: FINANCIAL OVERVIEW

FIGURE 22 SOLVIAS AG: SWOT ANALYSIS

FIGURE 23 SGS SA: FINANCIAL OVERVIEW

FIGURE 24 SGS SA: SWOT ANALYSIS

FIGURE 25 BOSTON ANALYTICAL: FINANCIAL OVERVIEW

FIGURE 26 BOSTON ANALYTICAL: SWOT ANALYSIS

FIGURE 27 BIOMÉRIEUX, INC.: FINANCIAL OVERVIEW

FIGURE 28 BIOMÉRIEUX, INC.: SWOT ANALYSIS

FIGURE 29 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: FINANCIAL OVERVIEW

FIGURE 30 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SWOT ANALYSIS

FIGURE 31 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW

FIGURE 32 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS

FIGURE 33 PACE ANALYTICAL SERVICES, LLC: FINANCIAL OVERVIEW

FIGURE 34 PACE ANALYTICAL SERVICES, LLC: SWOT ANALYSIS

FIGURE 35 TOXIKON, INC.: FINANCIAL OVERVIEW

FIGURE 36 TOXIKON, INC.: SWOT ANALYSIS

FIGURE 37 SOTERA HEALTH: FINANCIAL OVERVIEW

FIGURE 38 SOTERA HEALTH: SWOT ANALYSIS

FIGURE 39 PACIFIC BIOLABS INC.: FINANCIAL OVERVIEW

FIGURE 40 PACIFIC BIOLABS INC.: SWOT ANALYSIS

FIGURE 41 STRERIS CORPORATION: FINANCIAL OVERVIEW

FIGURE 42 STRERIS CORPORATION: SWOT ANALYSIS

FIGURE 43 WUXI APPTEC: FINANCIAL OVERVIEW

FIGURE 44 WUXI APPTEC: SWOT ANALYSIS